2007 annual financial data
XTL Biopharmaceuticals 2007 Operating margin
Direct answer
Operating margin was -2,837.38%.
Operating income was -25,735,000 USD and net income was -24,939,000 USD.
Operating cash flow was -21,457,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 907,000 USD
- Operating income
- -25,735,000 USD
- Net income
- -24,939,000 USD
- Operating cash flow
- -21,457,000 USD